-
China Center for Disease Control and Prevention (China CDC) (2020) http://m.news.cctv.com/2020/01/09/ARTI9Vp9Lra4Tvltz3r7es96200109.shtml. Accessed 9 Jan 2020
-
Huang CB, Wang Q, Xie GQ, Liu AH, Lai B, Chen YJ, Cheng YJ, Xu H, Han DM, 2004: Immunological characteristics of 1291 cases of severe acute respiratory syndrome in Beijing[J]. Zhonghua Nei Ke Za Zhi, 43, 406-409.
-
Kikkert M, 2020: Innate immune evasion by human respiratory RNA viruses[J]. J Innate Immun, 12, 4-20. doi: 10.1159/000503030
-
National Health Commission of the People's Republic of China (2007) National surveillance, investigation and management plan of unexplained pneumonia cases. 2007 (Code 158) http://www.nhc.gov.cn/bgt/pw10708/200708/4455f46a2f5e4908a8561c079ecbcf0e.shtml. Accessed 20 Jan 2020
-
Seillet C, Belz GT, Huntington ND, 2016: Development, homeostasis, and heterogeneity of NK cells and ILC1[J]. Curr Top Microbiol Immunol, 395, 37-61. doi: 10.1007/82_2015_474
-
Wang N, Li SY, Yang XL, Huang HM, Zhang YJ, Guo H, Luo CM, Miller M, Zhu GJ, Chmura AA, Emily E, Zhou JH, Zhang YZ, Wang LF, Daszak P, Zhi ZL, 2018: Serological evidence of bat SARS-related coronavirus infection in humans, China[J]. Virol Sin, 33, 104-107. doi: 10.1007/s12250-018-0012-7
-
World Health Organization (WHO) (2020) Novel Coronavirus—China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 12 Jan 2020
-
Wuhan Municipal Health Commission (WMHC) (2020) http://wjw.wuhan.gov.cn/front/web/showDetail/2020012009077. Accessed 20 Jan 2020
-
Zhang J, Feng X, Liu S, Dai W, He Z, Dong Q, Song S, Liu Z, Yao J, 2003: The study of B lymphocyte and NK cell in Severe Acute Respiratory Syndrome (SARS) patients[J]. Chin J Immunol, 19, 378-380.